• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性细胞死亡蛋白 1 形成负性共刺激微簇,通过募集磷酸酶 SHP2 直接抑制 T 细胞受体信号转导。

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

机构信息

Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama, Kanagawa 230-0045, Japan.

出版信息

J Exp Med. 2012 Jun 4;209(6):1201-17. doi: 10.1084/jem.20112741. Epub 2012 May 28.

DOI:10.1084/jem.20112741
PMID:22641383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3371732/
Abstract

Programmed cell death 1 (PD-1) is a negative costimulatory receptor critical for the suppression of T cell activation in vitro and in vivo. Single cell imaging elucidated a molecular mechanism of PD-1-mediated suppression. PD-1 becomes clustered with T cell receptors (TCRs) upon binding to its ligand PD-L1 and is transiently associated with the phosphatase SHP2 (Src homology 2 domain-containing tyrosine phosphatase 2). These negative costimulatory microclusters induce the dephosphorylation of the proximal TCR signaling molecules. This results in the suppression of T cell activation and blockade of the TCR-induced stop signal. In addition to PD-1 clustering, PD-1-TCR colocalization within microclusters is required for efficient PD-1-mediated suppression. This inhibitory mechanism also functions in PD-1(hi) T cells generated in vivo and can be overridden by a neutralizing anti-PD-L1 antibody. Therefore, PD-1 microcluster formation is important for regulation of T cell activation.

摘要

程序性细胞死亡蛋白 1(PD-1)是一种负性共刺激受体,对于体外和体内 T 细胞的激活具有抑制作用。单细胞成像揭示了 PD-1 介导的抑制的分子机制。PD-1 在与配体 PD-L1 结合后与 T 细胞受体(TCRs)聚集,并与磷酸酶 SHP2(Src 同源 2 结构域酪氨酸磷酸酶 2)短暂相关。这些负性共刺激微簇诱导 TCR 信号分子的去磷酸化。这导致 T 细胞激活的抑制和 TCR 诱导的停止信号的阻断。除了 PD-1 聚集外,微簇内的 PD-1-TCR 共定位对于有效的 PD-1 介导的抑制也是必需的。这种抑制机制也在体内产生的 PD-1(hi)T 细胞中起作用,并且可以被中和抗 PD-L1 抗体所克服。因此,PD-1 微簇的形成对于 T 细胞激活的调节很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/80fa56c50f8e/JEM_20112741_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/8972e567c20d/JEM_20112741_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/9ce11fb00fc8/JEM_20112741R_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/1f041dac408a/JEM_20112741_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/fe68ab7af6bc/JEM_20112741_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/7e3e1ac6ba31/JEM_20112741_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/3e8817aa2b01/JEM_20112741_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/5e832d1e729e/JEM_20112741R_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/7db9bfb2708c/JEM_20112741_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/80fa56c50f8e/JEM_20112741_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/8972e567c20d/JEM_20112741_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/9ce11fb00fc8/JEM_20112741R_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/1f041dac408a/JEM_20112741_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/fe68ab7af6bc/JEM_20112741_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/7e3e1ac6ba31/JEM_20112741_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/3e8817aa2b01/JEM_20112741_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/5e832d1e729e/JEM_20112741R_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/7db9bfb2708c/JEM_20112741_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aed/3371732/80fa56c50f8e/JEM_20112741_Fig9.jpg

相似文献

1
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.程序性细胞死亡蛋白 1 形成负性共刺激微簇,通过募集磷酸酶 SHP2 直接抑制 T 细胞受体信号转导。
J Exp Med. 2012 Jun 4;209(6):1201-17. doi: 10.1084/jem.20112741. Epub 2012 May 28.
2
PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment.PD-L2 通过共抑制微簇形成和 SHP2 磷酸酶募集来抑制 T 细胞信号转导。
Commun Biol. 2021 May 14;4(1):581. doi: 10.1038/s42003-021-02111-3.
3
T cell-specific constitutive active SHP2 enhances T cell memory formation and reduces T cell activation.T 细胞特异性组成型激活 SHP2 增强 T 细胞记忆形成并减少 T 细胞活化。
Front Immunol. 2022 Aug 2;13:958616. doi: 10.3389/fimmu.2022.958616. eCollection 2022.
4
PD-1 suppresses TCR-CD8 cooperativity during T-cell antigen recognition.PD-1 在 T 细胞抗原识别过程中抑制 TCR-CD8 的协同性。
Nat Commun. 2021 May 12;12(1):2746. doi: 10.1038/s41467-021-22965-9.
5
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.T细胞共刺激受体CD28是PD-1介导抑制作用的主要靶点。
Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9.
6
Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.体内CD4和CD8 T细胞介导的同种异体免疫反应中负性T细胞共刺激途径的作用分析
J Immunol. 2005 Jun 1;174(11):6648-56. doi: 10.4049/jimmunol.174.11.6648.
7
SHP-1 phosphatase activity counteracts increased T cell receptor affinity.SHP-1 磷酸酶活性可拮抗 T 细胞受体亲和力的增加。
J Clin Invest. 2013 Mar;123(3):1044-56. doi: 10.1172/JCI65325. Epub 2013 Feb 8.
8
PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.PD-1 和 BTLA 通过 SHP1 和 SHP2 差异化地调节 T 细胞信号传导,且仅部分如此。
J Cell Biol. 2020 Jun 1;219(6). doi: 10.1083/jcb.201905085.
9
Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.程序性死亡蛋白1(PD-1):PD-配体1的相互作用抑制T细胞受体介导的胸腺细胞阳性选择。
J Immunol. 2005 Dec 1;175(11):7372-9. doi: 10.4049/jimmunol.175.11.7372.
10
Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.淋巴内皮细胞通过 PD-L1 和缺乏共刺激诱导耐受,导致 CD8 T 细胞高水平表达 PD-1。
Blood. 2012 Dec 6;120(24):4772-82. doi: 10.1182/blood-2012-04-427013. Epub 2012 Sep 19.

引用本文的文献

1
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects.围手术期免疫检查点抑制剂用于治疗局部晚期胃癌和胃食管交界癌:现状与未来展望
Curr Treat Options Oncol. 2025 Sep 16. doi: 10.1007/s11864-025-01353-1.
2
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppression.肿瘤内外:胶质母细胞瘤诱导免疫抑制的机制
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv4-iv18. doi: 10.1093/noajnl/vdaf006. eCollection 2025 Sep.
3
Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape.

本文引用的文献

1
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.新型共刺激配体程序性死亡受体 1/B7.1 通路在体内抑制同种免疫反应中具有功能。
J Immunol. 2011 Aug 1;187(3):1113-9. doi: 10.4049/jimmunol.1100056. Epub 2011 Jun 22.
2
Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation.CTLA-4 共刺激分子介导的 T 细胞激活负调控的时空基础。
Immunity. 2010 Sep 24;33(3):326-39. doi: 10.1016/j.immuni.2010.09.006.
3
The PD-1 pathway in tolerance and autoimmunity.
揭示食管鳞状细胞癌中的免疫检查点耐药性:对肿瘤微环境和生物标志物格局的见解
World J Gastrointest Oncol. 2025 Aug 15;17(8):109489. doi: 10.4251/wjgo.v17.i8.109489.
4
Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder: A Retrospective Cohort Study of 40 Adult Patients.原发性皮肤CD4+小/中型T细胞淋巴增殖性疾病:40例成年患者的回顾性队列研究
Am J Dermatopathol. 2025 Jul 31;47(9):657-673. doi: 10.1097/DAD.0000000000002981.
5
Mechanistic insights into the immune biomarker of perioperative immune checkpoint inhibitors for non-small cell lung cancer.非小细胞肺癌围手术期免疫检查点抑制剂免疫生物标志物的机制性见解
Transl Lung Cancer Res. 2025 Jul 31;14(7):2821-2841. doi: 10.21037/tlcr-2025-162. Epub 2025 Jul 16.
6
THE BIOLOGY BEHIND PD-1 CHECKPOINT BLOCKADE.PD-1 检查点阻断背后的生物学原理。
Trans Am Clin Climatol Assoc. 2025;135:169-183.
7
Mechanical regulation of extracellular vesicle activity during tumour progression.肿瘤进展过程中细胞外囊泡活性的机械调节
Nat Biomed Eng. 2025 Aug 6. doi: 10.1038/s41551-025-01446-0.
8
Sending the Signal to Bone: How Tumor-Derived EVs Orchestrate Pre-Metastatic Niche Formation and Skeletal Colonization.向骨骼发送信号:肿瘤衍生的细胞外囊泡如何协调前转移微环境的形成和骨骼定植
Biomedicines. 2025 Jul 4;13(7):1640. doi: 10.3390/biomedicines13071640.
9
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion.程序性死亡受体1(PD-1)以细胞内源性和细胞外源性方式调节肿瘤浸润性CD8+T细胞。
J Exp Med. 2025 Oct 6;222(10). doi: 10.1084/jem.20230542. Epub 2025 Jul 24.
10
Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.从分子角度看癌症治疗中使用免疫检查点抑制剂(ICI)和抗血管生成药物的基本原理。
Clin Exp Med. 2025 Jul 8;25(1):238. doi: 10.1007/s10238-025-01751-7.
PD-1 通路在耐受和自身免疫中的作用。
Immunol Rev. 2010 Jul;236:219-42. doi: 10.1111/j.1600-065X.2010.00923.x.
4
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.PD-L1 调节诱导性调节 T 细胞的发育、维持和功能。
J Exp Med. 2009 Dec 21;206(13):3015-29. doi: 10.1084/jem.20090847. Epub 2009 Dec 14.
5
The immunological synapse, TCR microclusters, and T cell activation.免疫突触、TCR 微簇与 T 细胞激活。
Curr Top Microbiol Immunol. 2010;340:81-107. doi: 10.1007/978-3-642-03858-7_5.
6
PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia.表达C/EBPα的PD-1+记忆表型CD4+ T细胞是衰老和白血病中T细胞免疫抑制的基础。
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15807-12. doi: 10.1073/pnas.0908805106. Epub 2009 Sep 8.
7
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.程序性死亡受体1(PD-1)与程序性死亡配体1(PD-L1)之间的相互作用通过阻断T细胞受体(TCR)诱导的终止信号来促进免疫耐受。
Nat Immunol. 2009 Nov;10(11):1185-92. doi: 10.1038/ni.1790. Epub 2009 Sep 27.
8
PD-1 signaling in primary T cells.初始T细胞中的PD-1信号传导。
Immunol Rev. 2009 May;229(1):114-25. doi: 10.1111/j.1600-065X.2009.00767.x.
9
Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters.通过TCR-CD28微簇对T细胞共刺激进行动态调节。
Immunol Rev. 2009 May;229(1):27-40. doi: 10.1111/j.1600-065X.2009.00779.x.
10
Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation.通过TCR-CD28微簇和蛋白激酶Cθ易位对T细胞共刺激的时空调节。
Immunity. 2008 Oct 17;29(4):589-601. doi: 10.1016/j.immuni.2008.08.011. Epub 2008 Oct 9.